Drug-eluting stents versus bare-metal stents in acute myocardial infarction: A systematic review and meta-analysis

International Journal of Technology Assessment in Health Care

Volumn 27, Issue 1, 2011, Pages 11-22

  Suh, Hae Sun ^a   Song, Hyun Jin ^a   Choi, Ji Eun ^a   Jang, Eun Jin ^a   Son, Hee Jeong ^a   Lee, Sang Moo ^a   Kim, Jung Sun ^b   Choi, Donghoon ^b  

^a National Evidence Based Healthcare Collaborating Agency   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Drug eluting stents; Meta analysis; Myocardial infarction; Systematic review

Indexed keywords

ACUTE MYOCARDIAL INFARCTION; CONFIDENCE INTERVAL; DRUG-ELUTING STENTS; META-ANALYSIS; MYOCARDIAL INFARCTION; OBSERVATIONAL DATA; OBSERVATIONAL STUDY; RANDOM EFFECTS MODEL; RANDOMIZED CONTROLLED TRIAL; RELATIVE IMPACT; REVASCULARIZATION; STRATIFIED ANALYSIS; STUDY DESIGN; SYSTEMATIC REVIEW; TARGET VESSELS;

LINEAR TRANSFORMATIONS;

ARTIFICIAL ORGANS;

ABCIXIMAB; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; TIROFIBAN; ZOTAROLIMUS;

ACUTE HEART INFARCTION; ARTICLE; BARE METAL STENT; BLOOD VESSEL PARAMETERS; DATA EXTRACTION; DRUG ELUTING STENT; EMBASE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MEDICAL LITERATURE; MEDLINE; MESH HEADING; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; QUALITATIVE ANALYSIS; STENT THROMBOSIS; SYSTEMATIC REVIEW; TARGET VESSEL REVASCULARIZATION; ACUTE DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STANDARD; TREATMENT OUTCOME;

ACUTE DISEASE; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 79955702359     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462310001340     Document Type: Article

References (28)

1. Brar SS, Leon MB, Stone GW, et al. Use of drug-eluting stents in acute myocardial infarction: A systematic review and meta-analysis. J Am Coll Cardiol. 2009;53:1677-1689.
2. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
3. De Luca G, Stone GW, Suryapranata H, et al. Efficacy and safety of drug-eluting stents in ST-segment elevation myocar-dial infarction: A meta-analysis of randomized trials. Int J Car-diol. 2009;133:213-222.
4. De Luca G, Valgimigli M, Spaulding C, et al. Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. J Thromb Thrombolysis. 2009;28:200-210.
5. DerSimonian R, Laird N. Meta-analysis in clinical trials. Con¬trol Clin Trials. 1986;7:177-188. (Pubitemid 17189972)
6. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455-463. (Pubitemid 30422636)
7. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634. (Pubitemid 27387172)
8. Finn AV, Nakazawa G, Kolodgie F, Virmani R. Drug eluting or bare metal stent for acute myocardial infarction: An issue of safety? Eur Heart J. 2009;30:1828-1830.
9. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerg¬ing consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926. (Pubitemid 351632017)
10. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. www.cochrane-handbook.org (accessed October 1, 2009).
11. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. (Pubitemid 37088507)
12. Hill RA, Boland A, Dickson R, et al. Drug-eluting stents: A systematic review and economic evaluation. Health Technol Assess. 2007;11:iii, xi-221.
13. Iijima R, Byrne RA, Dibra A, et al. Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: A pooled analysis of individual patient data from seven randomized trials. Rev Esp Cardiol. 2009;62:354-364.
14. Kastrati A, Dibra A, Spaulding C, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28:2706-2713. (Pubitemid 350139205)
15. Kim SS, Park DW, Seo JS, et al. Abstract AS-190: Long-term clinical outcomes with drug-eluting versus bare metal stents in ST-segment elevation myocardial infarction. Am J Cardiol. 2009;103(Suppl 1):81B.
16. Kushner FG, Hand M, Smith SC Jr, et al. 2009. Focused updates: ACC/AHA Guidelines for the management of pa¬tients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI Guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120:2271-2306.
17. Kuukasjarvi P, Malmivaara A, Halinen M, et al. Overview of systematic reviews on invasive treatment of stable coronary artery disease. Int J Technol Assess Health Care. 2006;22:219-234.
18. Moreno R, Fernandez C, Calvo L, et al. Meta-analysis compar¬ing the effect of drug-eluting versus bare metal stents on risk of acute myocardial infarction during follow-up. Am J Cardiol. 2007;99:621-625.
19. Nakamura S, Bae J, Cahyadi YH, et al. Three-year follow-up of patients with ST-segment evelation acute myocardial infarction treated with sirolimus-eluting stent and paclitaxel-eluting stent: Multicenter registry in Asia. Circulation. 2006;114(II-516):Abstract 2503.
20. NECA. Drug-eluting stents versus bare-metal stents in acute myocardial infarction (NA2009-015). Seoul, Korea: The National Evidence-based Healthcare Collaborating Agency (NECA); 2010.
21. Nordmann AJ, Hengstler P, Leimenstoll BM, et al. Clinical out¬comes of stents versus balloon angioplasty in non-acute coro¬nary artery disease. Eur Heart J. 2004;25:69-80. (Pubitemid 38055595)
22. Pan XH, Zhong WZ, Xiang MX, et al. Clinical outcomes of serolimus-eluting stents versus bare metal stents in ST-segment elevation myocardial infarction patients: A meta-analysis. Chin Med J (Engl). 2009;122:88-92.
23. Park KW, Kang SH, Lee HY, et al. Abstract TCT-315: 'Real World' comparison of drug-eluting stents versus bare metal stents in the treatment of unselected patients with acute ST-segment elevation myocardial infarction: Mid to long term re¬sults from a two center registry. Am J Cardiol. 2008;102(Suppl 1):128i.
24. Pasceri V, Patti G, Speciale G, et al. Meta-analysis of clini¬cal trials on use of drug-eluting stents for treatment of acute myocardial infarction. Am Heart J. 2007;153:749-754. (Pubitemid 46602146)
25. Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M. Clinical impact of sirolimus-eluting stent in ST-segment ele¬vation myocardial infarction: A meta-analysis of randomized clinical trials. Catheter Cardiovasc Interv. 2009;74:323-332.
26. Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62:1013-1020.
27. Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (MINORS): Development and validation of a new instrument. ANZ J Surg. 2003;73:712-716. (Pubitemid 37267119)
28. Valgimigli M, Campo G, Arcozzi C, et al. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent im¬plantation assisted by systematic glycoprotein IIb/IIIa inhibitor infusion in patients with myocardial infarction: Results from the STRATEGY study. J Am Coll Cardiol. 2007;50:138-145. (Pubitemid 47002182)